| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001523 | Retinoid metabolic process | Increases phenotype | PMID:33992733 |
| GO:0001755 | Neural crest cell migration | Decreases phenotype | PMID:26238599 |
| GO:0002440 | Production of molecular mediator of immune response | Increases phenotype | PMID:18995849 |
| GO:0006897 | Endocytosis | Increases phenotype | PMID:26141388 |
| GO:0006973 | Intracellular accumulation of glycerol | Increases phenotype | PMID:39793953 |
| GO:0007612 | Learning | Affects phenotype | PMID:32521479 |
| GO:0007616 | Long-term memory | Decreases phenotype | PMID:26480858 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:25659934 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:29704545 |
| GO:0030502 | Negative regulation of bone mineralization | Increases phenotype | PMID:33992733 |
| GO:0032204 | Regulation of telomere maintenance | Affects phenotype | PMID:32300848 |
| GO:0032637 | Interleukin-8 production | Affects phenotype | PMID:22326254 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:16079076; PMID:19750101 |
| GO:0042445 | Hormone metabolic process | Affects phenotype | PMID:17938741 |
| GO:0043433 | Negative regulation of dna-binding transcription factor activity | Increases phenotype | PMID:26022396 |
| GO:0044027 | Hypermethylation of cpg island | Affects phenotype | PMID:25585924 |
| GO:0044255 | Cellular lipid metabolic process | Increases phenotype | PMID:24978599 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:33992733 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:33992733 |
| GO:0048589 | Developmental growth | Decreases phenotype | PMID:21851983 |
| GO:0050847 | Progesterone receptor signaling pathway | Decreases phenotype | PMID:26022396 |
| GO:0050890 | Cognition | Decreases phenotype | PMID:18288320 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:25659934 |
| GO:0098868 | Bone growth | Increases phenotype | PMID:33992733 |
| GO:2000610 | Negative regulation of thyroid hormone generation | Increases phenotype | PMID:33992733 |
| GO:2000612 | Regulation of thyroid-stimulating hormone secretion | Affects phenotype | PMID:19750101 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:33992733 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.